Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Commentary on: Norberg H, Kowalski J, Maršál K, et al. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG 2017. doi: 10.1111/1471-0528.14545. [Epub ahead of print 15 March 2017].
Antenatal corticosteroids (ACS) reduce mortality in preterm infants.1 The association between timing of ACS and outcomes among extremely preterm infants has been sparsely investigated. In a recent large retrospective cohort study, higher odds for severe neonatal morbidity or mortality were seen in infants born at 24–33 weeks gestation with an administration-to-birth interval of ACS <1 or>7 days compared with 1–7 days.2 The objective of this study was to investigate the impact of ACS administration-to-birth interval on survival among extremely preterm infants.
This population-based cohort study used data collected prospectively …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.